[go: up one dir, main page]

GB0517386D0 - Combinations for the treatment of cancer - Google Patents

Combinations for the treatment of cancer

Info

Publication number
GB0517386D0
GB0517386D0 GB0517386A GB0517386A GB0517386D0 GB 0517386 D0 GB0517386 D0 GB 0517386D0 GB 0517386 A GB0517386 A GB 0517386A GB 0517386 A GB0517386 A GB 0517386A GB 0517386 D0 GB0517386 D0 GB 0517386D0
Authority
GB
United Kingdom
Prior art keywords
cancer
combinations
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GB0517386A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Antisoma Research Ltd
Original Assignee
Antisoma Research Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Antisoma Research Ltd filed Critical Antisoma Research Ltd
Priority to GB0517386A priority Critical patent/GB0517386D0/en
Publication of GB0517386D0 publication Critical patent/GB0517386D0/en
Priority to JP2008527517A priority patent/JP2009506019A/en
Priority to CA002620436A priority patent/CA2620436A1/en
Priority to CNA2006800404812A priority patent/CN101309681A/en
Priority to BRPI0614965A priority patent/BRPI0614965A2/en
Priority to AU2006283371A priority patent/AU2006283371A1/en
Priority to PCT/GB2006/003196 priority patent/WO2007023302A1/en
Priority to EP06779226A priority patent/EP1917011A1/en
Priority to KR1020087006684A priority patent/KR20080047402A/en
Priority to RU2008111492/15A priority patent/RU2404764C2/en
Priority to US12/064,633 priority patent/US20100297112A1/en
Priority to TNP2008000056A priority patent/TNSN08056A1/en
Priority to NO20080649A priority patent/NO20080649L/en
Priority to IL189376A priority patent/IL189376A0/en
Priority to EC2008008243A priority patent/ECSP088243A/en
Priority to MA30756A priority patent/MA29786B1/en
Ceased legal-status Critical Current

Links

GB0517386A 2005-08-26 2005-08-26 Combinations for the treatment of cancer Ceased GB0517386D0 (en)

Priority Applications (16)

Application Number Priority Date Filing Date Title
GB0517386A GB0517386D0 (en) 2005-08-26 2005-08-26 Combinations for the treatment of cancer
US12/064,633 US20100297112A1 (en) 2005-08-26 2006-08-25 Combinations comprising dmxaa for the treatment of cancer
PCT/GB2006/003196 WO2007023302A1 (en) 2005-08-26 2006-08-25 Combinations comprising dmxaa for the treatment of cancer
KR1020087006684A KR20080047402A (en) 2005-08-26 2006-08-25 Combination for Cancer Therapeutic Including DMBAA
CNA2006800404812A CN101309681A (en) 2005-08-26 2006-08-25 Combinations containing DMXAA for the treatment of cancer
BRPI0614965A BRPI0614965A2 (en) 2005-08-26 2006-08-25 method for modulating neoplastic growth, uses of a compound or a pharmaceutically acceptable salt, ester or prodrug thereof, a vascular endothelial growth factor binder, and a taxane, pharmaceutical formulation, and kit
AU2006283371A AU2006283371A1 (en) 2005-08-26 2006-08-25 Combinations comprising DMXAA for the treatment of cancer
JP2008527517A JP2009506019A (en) 2005-08-26 2006-08-25 Combinations for cancer treatment
EP06779226A EP1917011A1 (en) 2005-08-26 2006-08-25 Combinations comprising dmxaa for the treatment of cancer
CA002620436A CA2620436A1 (en) 2005-08-26 2006-08-25 Combinations comprising dmxaa for the treatment of cancer
RU2008111492/15A RU2404764C2 (en) 2005-08-26 2006-08-25 Combinations (compositions), including dmxaa for cancer treatment
NO20080649A NO20080649L (en) 2005-08-26 2008-02-06 Compounds comprising DMXAA for the treatment of cancer
TNP2008000056A TNSN08056A1 (en) 2005-08-26 2008-02-06 Combinations comprising dmxaa for the treatment of cancer
IL189376A IL189376A0 (en) 2005-08-26 2008-02-07 Combinations comprising dmxaa for the treatment of cancer
EC2008008243A ECSP088243A (en) 2005-08-26 2008-03-05 COMBINATIONS UNDERSTANDING DMXAA FOR CANCER TREATMENT
MA30756A MA29786B1 (en) 2005-08-26 2008-03-17 COMBINATIONS FOR THE TREATMENT OF CANCER

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0517386A GB0517386D0 (en) 2005-08-26 2005-08-26 Combinations for the treatment of cancer

Publications (1)

Publication Number Publication Date
GB0517386D0 true GB0517386D0 (en) 2005-10-05

Family

ID=35198383

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0517386A Ceased GB0517386D0 (en) 2005-08-26 2005-08-26 Combinations for the treatment of cancer

Country Status (2)

Country Link
CN (1) CN101309681A (en)
GB (1) GB0517386D0 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109223764B (en) * 2018-11-19 2021-01-26 上海市第一人民医院 Application of DMXAA in preparation of hypoglycemic drugs

Also Published As

Publication number Publication date
CN101309681A (en) 2008-11-19

Similar Documents

Publication Publication Date Title
IL188746A0 (en) Treatment of cancer
IL191832A0 (en) Pyridiazinone derivatives for the treatment of tumours
IL188430A0 (en) Treatment of tumors
PT1830847E (en) Treatment for cancer
IL189377A0 (en) Combinations comprising dmxaa for the treatment of cancer
IL189376A0 (en) Combinations comprising dmxaa for the treatment of cancer
GB0428187D0 (en) Cancer treatment
AU2006251167A8 (en) Tetrahydropyridothiophenes for use in the treatment of cancer
AU2006251169A8 (en) Tetrahydropyridothiophenes for use in the treatment of cancer
IL187792A0 (en) 4-anilino-3-quinolinecarbonitriles for the treatment of cancer
EP1867640A4 (en) Agent for treatment of solid tumor
GB0516068D0 (en) Well treatment
ZA200805522B (en) Dioxoiane dérivates for the treatment of cancer
IL226362A0 (en) Compounds, and methods for the treatment of cancer
GB0803521D0 (en) A pharmaceutcal composition useful for the treatment of prostate cancer
GB0511769D0 (en) Treatment
GB0520067D0 (en) Treatment of cancer
ZA200706871B (en) Treatment of metastasized tumors
GB0502171D0 (en) Well treatment
GB0525535D0 (en) Tumour treatment
GB0517386D0 (en) Combinations for the treatment of cancer
GB0404675D0 (en) Cancer treatment
GB0507685D0 (en) Cancer treatment
GB0710871D0 (en) Cancer treatment
GB0604114D0 (en) Combinations for the treatment of cancer

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)